Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content ++ Systemic inflammatory response syndrome (SIRS): systemic response to any inflammatory/infectious etiology (see Table 199-1) ++ Sepsis: definite infectious etiology with a resultant systemic response (at least two or more SIRS criteria)Severe sepsis → sepsis with acute organ dysfunctionSeptic shock → sepsis-induced hypotension refractory to fluid resuscitation and evidence of end-organ damage including lactic acidosis, oliguria, or altered mental statusMortality ranges from 28% to 50% ++Table Graphic Jump LocationTable 199-1 SIRS Criteria (Need 2 out Of 4)View Table||Download (.pdf)Table 199-1 SIRS Criteria (Need 2 out Of 4)WBC >12,000/mL, <4,000/mL, or >10% immature bandsHR >90/minTemperature >38.5°C or <35°CRR >20 breaths/min, or Paco2 <32 mm Hg++Figure 199-1. Diagnostic Workup of SepsisGraphic Jump LocationView Full Size||Download Slide (.ppt)++Table Graphic Jump Location|Download (.pdf)|PrintManagement of Severe Sepsis or Septic ShockInitial resuscitation (first 6 h)Patients with hypotension, lactic acid >4 mmol/L require immediate resuscitationGoalsMean arterial pressure ≥65 mm HgUrine output ≥0.5 mL/kg/hCentral venous pressure (CVP) 8–12 mm Hg (controversial benefit)Central venous oxygen saturation ≥70% or mixed venous ≥65% (controversial benefit)Crystalloids and colloids equally effectiveChallenges of 1,000 mL of crystalloid or 300–500 mL of colloid over 30 minMay require larger volumes in patients with persistent hypotension with vasopressorsBicarbonate therapy contraindicated in patients with hypoperfusion-induced lactic acidosis and pH ≥7.15Blood product transfusionTransfuse packed red blood cells to target Hb ≥7 (may require higher targets in patients with special circumstances [myocardial ischemia, etc.])Avoid plasma or platelet administration unless active bleeding or planned procedureVasopressorsStart if shock persists despite fluid resuscitation (20–30 mL/kg) to keep MAP ≥60–65 mm HgVasopressors, including norepinephrine and dopamine, should be administered via central venous catheterVasopressin (0.03 U/min), phenylephrine, or epinephrine may be added if shock unresponsive to initial vasoactive medicationsArterial catheter use recommended for hemodynamic monitoringDobutamine recommended in patients with myocardial dysfunctionSource control and antibioticsIdentify infectious etiology within 6 h of presentationEvaluate and implement measures of source control (abscess drainage, tissue debridement, etc.)Remove infected intravascular devicesCulture all available specimensStart broad-spectrum antibiotics within the first hour as sepsis and septic shock recognized Combination therapy should be used in patients with suspected Pseudomonas infection or who are otherwise immunocompromisedMechanical ventilation in patients with ALI/ARDSTidal volume of 6 mL/kg (ideal body weight)Maintain plateau pressures ≤30 cm H2OIncrease PEEP as needed to avoid lung collapse at end-expiration and to avoid oxygen toxicity with high FiO2 levelsAllow Paco2 to rise to minimize plateau pressures and tidal volumesKeep head of bed elevated to at least 30° (30–45°), unless contraindicatedInstitute weaning protocols and daily assessment for SBT to liberate patients from mechanical ventilationUse conservative fluid strategySome advocate against PAC in patients with ALI/ARDS: no survival benefit, ... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.